DICER1 and hematologic disorder: Our study further expands this understanding by showing that dysregulation of DICER1 and DROSHA is a common feature in hematologic malignancies, not only in myeloid neoplasms but also in lymphoid disorders such as Hodgkin lymphoma [17].